Molecular alterations underlying Doxorubicin’s Chronic Cardiotoxicity in a mouse model
Sofia Reis Brandão,
Ana Reis-Mendes,
Margarida Duarte-Araújo,
Maria João Neuparth,
Félix Carvalho,
Rita Ferreira,
Vera Marisa Costa
Affiliations
Sofia Reis Brandão
Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal; LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
Ana Reis-Mendes
Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Margarida Duarte-Araújo
Department of Immuno-Physiology and Pharmacology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal.
Maria João Neuparth
Research Centre in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto, Porto, Portugal; TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU CRL, Gandra, Portugal.
Félix Carvalho
Associate Laboratory i4HB - Institute for Health and Bioeconomy
Rita Ferreira
LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
Vera Marisa Costa
Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
